Stock 5G3 TALKMED GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials TalkMed Group Limited

Equities

5G3

SG2G61000003

Healthcare Facilities & Services

Market Closed - Singapore S.E.
Other stock markets
 04:48:02 2024-04-25 am EDT 		5-day change 1st Jan Change
0.415 SGD +3.75% Intraday chart for TalkMed Group Limited +1.22% +9.21%
Apr. 18 TalkMed Group Limited Approves Final One-Tier Tax-Exempt Dividend for the Financial Year Ended 31 December 2023 CI
Apr. 17 TalkMed Reaches Final Settlement in Mediation Related to Claims in Stem Med Stake Disposal MT

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 788.6 677 593.1 514.8 529 503.7
Enterprise Value (EV) 1 719.7 605.5 523.8 441.7 454.9 423
P/E ratio 27.3 x 18.9 x 26.2 x 20.6 x 17.4 x 15.7 x
Yield 3.04% 4.47% 3% 4.1% 7.5% 5.79%
Capitalization / Revenue 12.9 x 8.91 x 9.52 x 8.45 x 6.91 x 6.01 x
EV / Revenue 11.7 x 7.97 x 8.41 x 7.25 x 5.94 x 5.05 x
EV / EBITDA 20.9 x 14.1 x 18.4 x 16.2 x 11.5 x 10.7 x
EV / FCF 38 x 23.9 x 22.8 x 25.7 x 15.7 x 13.2 x
FCF Yield 2.63% 4.19% 4.38% 3.9% 6.35% 7.59%
Price to Book 10.7 x 8.15 x 7.11 x 5.71 x 5.96 x 5.59 x
Nbr of stocks (in thousands) 1,314,286 1,314,502 1,318,055 1,320,109 1,322,555 1,325,519
Reference price 2 0.6000 0.5150 0.4500 0.3900 0.4000 0.3800
Announcement Date 4/9/19 4/3/20 4/4/21 4/3/22 4/5/23 4/2/24
1SGD in Million2SGD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 61.31 75.97 62.31 60.91 76.6 83.79
EBITDA 1 34.46 42.93 28.53 27.35 39.42 39.49
EBIT 1 34.08 41.46 27.11 26.96 38.9 38.83
Operating Margin 55.59% 54.58% 43.5% 44.26% 50.79% 46.34%
Earnings before Tax (EBT) 1 34 41.35 24.81 27.29 36.85 37.82
Net income 1 28.91 35.75 22.77 25.12 30.55 32.18
Net margin 47.15% 47.06% 36.54% 41.23% 39.88% 38.4%
EPS 2 0.0220 0.0272 0.0172 0.0189 0.0230 0.0242
Free Cash Flow 1 18.96 25.36 22.95 17.21 28.89 32.12
FCF margin 30.92% 33.38% 36.82% 28.25% 37.72% 38.34%
FCF Conversion (EBITDA) 55.01% 59.07% 80.43% 62.92% 73.29% 81.35%
FCF Conversion (Net income) 65.57% 70.92% 100.78% 68.52% 94.58% 99.83%
Dividend per Share 2 0.0183 0.0230 0.0135 0.0160 0.0300 0.0220
Announcement Date 4/9/19 4/3/20 4/4/21 4/3/22 4/5/23 4/2/24
1SGD in Million2SGD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 68.9 71.4 69.3 73.1 74.2 80.7
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 19 25.4 22.9 17.2 28.9 32.1
ROE (net income / shareholders' equity) 37.3% 42.3% 23.1% 25.8% 33.7% 34.8%
ROA (Net income/ Total Assets) 24.1% 26.3% 16.1% 15.8% 22.3% 21.6%
Assets 1 119.8 136.1 141.6 159.1 136.9 149.1
Book Value Per Share 2 0.0600 0.0600 0.0600 0.0700 0.0700 0.0700
Cash Flow per Share 2 0.0100 0.0100 0.0100 0.0100 0.0200 0.0100
Capex 1 3.93 2.13 1.95 0.77 0.31 0.7
Capex / Sales 6.41% 2.8% 3.14% 1.26% 0.41% 0.84%
Announcement Date 4/9/19 4/3/20 4/4/21 4/3/22 4/5/23 4/2/24
1SGD in Million2SGD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
TALKMED GROUP LIMITED Stock TalkMed Group Limited
+9.21% 404M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.92% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.36B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.77B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.72B
DAVITA INC. Stock DaVita Inc.
+27.44% 11.71B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. 5G3 Stock
  4. Financials TalkMed Group Limited